Abstract
Aryl hydrocarbon receptor (AhR), a cellular chemical sensor, controls cellular homeostasis, and sphingosine-1-phosphate (S1P), a bioactive intermediate of sphingolipid metabolism, is believed to have a role in immunity and inflammation, but their potential crosstalk is currently unknown. We aimed to determine whether there is a functional linkage between AhR signaling and sphingolipid metabolism. We showed that AhR ligands, including an environmental polycyclic aromatic hydrocarbon (PAH), induced S1P generation, and inhibited S1P lyase (S1PL) activity in resting cells, antigen/IgE-activated mast cells, and mouse lungs exposed to the AhR ligand alone or in combination with antigen challenge. The reduction of S1PL activity was due to AhR-mediated oxidation of S1PL at residue 317, which was reversible by the addition of an antioxidant or in cells with knockdown of the ORMDL3 gene encoding an ER transmembrane protein, whereas C317A S1PL mutant-transfected cells were resistant to the AhR-mediated effect. Furthermore, analysis of AhR ligand-treated cells showed a time-dependent increase of the ORMDL3–S1PL complex, which was confirmed by FRET analysis. This change increased the S1P levels, which in turn, induced mast cell degranulation via S1PR2 signaling. In addition, elevated levels of plasma S1P were found in children with asthma compared to non-asthmatic subjects. These results suggest a new regulatory pathway whereby the AhR–ligand axis induces ORMDL3-dependent S1P generation by inhibiting S1PL, which may contribute to the expression of allergic diseases.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Change history
16 May 2018
In this article, published online 23 March 2018, the affiliation 10 of Zhou Y was incorrect. The affiliation should be “Children’s Hospital and Institute of Biomedical Sciences, Fudan University. Key Laboratory of Neonatal Disease, Ministry of Health, 201102, Shanghai, China.” The authors regret the errors.
References
Nguyen, N. T., Hanieh, H., Nakahama, T. & Kishimoto, T. The roles of aryl hydrocarbon receptor in immune responses. Int. Immunol. 25, 335–43 (2013).
Sibilano, R., Pucillo, C. E. & Gri, G. Allergic responses and aryl hydrocarbon receptor novel pathway of mast cell activation. Mol. Immunol. 63, 69–73 (2015).
Quintana, F. J. The aryl hydrocarbon receptor: a molecular pathway for the environmental control of the immune response. Immunology 138, 183–9 (2013).
Veldhoen, M., Hirota, K., Westendorf, A. M., Buer, J., Dumoutier, L. & Renauld, J. C. et al. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 453, 106–9 (2008).
Zhou, Y., Tung, H. Y., Tsai, Y. M., Hsu, S. C., Chang, H. W. & Kawasaki, H. et al. Aryl hydrocarbon receptor controls murine mast cell homeostasis. Blood 121, 3195–204 (2013).
Wang, H. C., Zhou, Y. & Huang, S. K. SHP-2 phosphatase controls aryl hydrocarbon receptor-mediated ER stress response in mast cells. Arch. Toxicol. 91, 1739–48 (2017).
Breslow, D. K., Collins, S. R., Bodenmiller, B., Aebersold, R., Simons, K. & Shevchenko, A. et al. Orm family proteins mediate sphingolipid homeostasis. Nature 463, 1048–53 (2010).
Oyeniran, C., Sturgill, J. L., Hait, N. C., Huang, W. C., Avni, D. & Maceyka, M. et al. Aberrant ORM (yeast)-like protein isoform 3 (ORMDL3) expression dysregulates ceramide homeostasis in cells and ceramide exacerbates allergic asthma in mice. J. Allergy Clin. Immunol. 136, 1035–46 (2015).
Kiefer, K., Carreras-Sureda, A., Garcia-Lopez, R., Rubio-Moscardo, F., Casas, J. & Fabrias, G. et al. Coordinated regulation of the orosomucoid-like gene family expression controls de novo ceramide synthesis in mammalian cells. J. Biol. Chem. 290, 2822–30 (2015).
Zhakupova, A., Debeuf, N., Krols, M., Toussaint, W., Vanhoutte, L. & Alecu, I. et al. ORMDL3 expression levels have no influence on the activity of serine palmitoyltransferase. FASEB J. 30, 4289–300 (2016).
Siow, D., Sunkara, M., Dunn, T. M., Morris, A. J. & Wattenberg, B. ORMDL/serine palmitoyltransferase stoichiometry determines effects of ORMDL3 expression on sphingolipid biosynthesis. J. Lipid Res. 56, 898–908 (2015).
Miller, M., Rosenthal, P., Beppu, A., Gordillo, R. & Broide, D. H. Oroscomucoid such as protein 3 (ORMDL3) transgenic mice have reduced levels of sphingolipids including sphingosine-1-phosphate and ceramide. J. Allergy Clin. Immunol. 139, 1373–6 (2017).
Moffatt, M. F., Kabesch, M., Liang, L., Dixon, A. L., Strachan, D. & Heath, S. et al. Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature 448, 470–3 (2007).
Balantic, M., Rijavec, M., Flezar, M., Camlek, T., Hudoklin, I. & Kosnik, M. et al. A polymorphism in ORMDL3 is associated not only with asthma without rhinitis but also with chronic obstructive pulmonary disease. J. Investig. Allergol. Clin. Immunol. 23, 256–61 (2013).
Barrett, J. C., Hansoul, S., Nicolae, D. L., Cho, J. H., Duerr, R. H. & Rioux, J. D. et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn’s disease. Nat. Genet. 40, 955–62 (2008).
McGovern, D. P., Gardet, A., Torkvist, L., Goyette, P., Essers, J. & Taylor, K. D. et al. Genome-wide association identifies multiple ulcerative colitis susceptibility loci. Nat. Genet. 42, 332–7 (2010).
Kurreeman, F. A., Stahl, E. A., Okada, Y., Liao, K., Diogo, D. & Raychaudhuri, S. et al. Use of a multiethnic approach to identify rheumatoid- arthritis-susceptibility loci, 1p36 and 17q12. Am. J. Hum. Genet. 90, 524–32 (2012).
Cantero-Recasens, G., Fandos, C., Rubio-Moscardo, F., Valverde, M. A. & Vicente, R. The asthma-associated ORMDL3 gene product regulates endoplasmic reticulum-mediated calcium signaling and cellular stress. Hum. Mol. Genet. 19, 111–21 (2010).
Miller, M., Tam, A. B., Cho, J. Y., Doherty, T. A., Pham, A. & Khorram, N. et al. ORMDL3 is an inducible lung epithelial gene regulating metalloproteases, chemokines, OAS, and ATF6. Proc. Natl Acad. Sci. USA 109, 16648–53 (2012).
Miller, M., Tam, A. B., Mueller, J. L., Rosenthal, P., Beppu, A. & Gordillo, R. et al. Cutting edge: targeting epithelial ORMDL3 increases, rather than reduces, airway responsiveness and is associated with increased sphingosine-1-phosphate. J. Immunol. 198, 3017–22 (2017).
Miller, M., Rosenthal, P., Beppu, A., Mueller, J. L., Hoffman, H. M. & Tam, A. B. et al. ORMDL3 transgenic mice have increased airway remodeling and airway responsiveness characteristic of asthma. J. Immunol. 192, 3475–87 (2014).
Rosenfeldt, H. M., Amrani, Y., Watterson, K. R., Murthy, K. S., Panettieri, R. A. Jr. & Spiegel, S. Sphingosine-1-phosphate stimulates contraction of human airway smooth muscle cells. FASEB J. 17, 1789–99 (2003).
Worgall, T. S., Veerappan, A., Sung, B., Kim, B. I., Weiner, E. & Bholah, R. et al. Impaired sphingolipid synthesis in the respiratory tract induces airway hyperreactivity. Sci. Transl. Med. 5, 186ra167 (2013).
Maceyka, M. & Spiegel, S. Sphingolipid metabolites in inflammatory disease. Nature 510, 58–67 (2014).
Olivera, A. & Rivera, J. An emerging role for the lipid mediator sphingosine-1-phosphate in mast cell effector function and allergic disease. Adv. Exp. Med. Biol. 716, 123–42 (2011).
Serra, M. & Saba, J. D. Sphingosine 1-phosphate lyase, a key regulator of sphingosine 1-phosphate signaling and function. Adv. Enzyme Regul. 50, 349–62 (2010).
Oskeritzian, C. A., Price, M. M., Hait, N. C., Kapitonov, D., Falanga, Y. T. & Morales, J. K. et al. Essential roles of sphingosine-1-phosphate receptor 2 in human mast cell activation, anaphylaxis, and pulmonary edema. J. Exp. Med. 207, 465–74 (2010).
Jolly, P. S., Bektas, M., Olivera, A., Gonzalez-Espinosa, C., Proia, R. L. & Rivera, J. et al. Transactivation of sphingosine-1-phosphate receptors by Fc epsilon RI triggering is required for normal mast cell degranulation and chemotaxis. J. Exp. Med. 199, 959–70 (2004).
Oskeritzian, C. A., Milstien, S. & Spiegel, S. Sphingosine-1-phosphate in allergic responses, asthma and anaphylaxis. Pharmacol. Ther. 115, 390–9 (2007).
Zhan, X. & Desiderio, D. M. Nitroproteins from a human pituitary adenoma tissue discovered with a nitrotyrosine affinity column and tandem mass spectrometry. Anal. Biochem. 354, 279–89 (2006).
Van Veldhoven, P. P., Gijsbers, S., Mannaerts, G. P., Vermeesch, J. R. & Brys, V. Human sphingosine-1-phosphate lyase: cDNA cloning, functional expression studies and mapping to chromosome 10q22(1). Biochim. Biophys. Acta 1487, 128–34 (2000).
Bourquin, F., Riezman, H., Capitani, G. & Grutter, M. G. Structure and function of sphingosine-1-phosphate lyase, a key enzyme of sphingolipid metabolism. Structure 18, 1054–65 (2010).
Suh, J. H. & Saba, J. D. Sphingosine-1-phosphate in inflammatory bowel disease and colitis-associated colon cancer: the fat’s in the fire. Transl. Cancer Res. 4, 469–83 (2015).
Miller, R. L., Garfinkel, R., Lendor, C., Hoepner, L., Li, Z. & Romanoff, L. et al. Polycyclic aromatic hydrocarbon metabolite levels and pediatric allergy and asthma in an inner-city cohort. Pediatr. Allergy Immunol. 21, 260–7 (2010).
Olivera, A., Urtz, N., Mizugishi, K., Yamashita, Y., Gilfillan, A. M. & Furumoto, Y. et al. IgE-dependent activation of sphingosine kinases 1 and 2 and secretion of sphingosine 1-phosphate requires Fyn kinase and contributes to mast cell responses. J. Biol. Chem. 281, 2515–25 (2006).
Huang, S. K., Zhang, Q., Qiu, Z. & Chung, K. F. Mechanistic impact of outdoor air pollution on asthma and allergic diseases. J. Thorac. Dis. 7, 23–33 (2015).
Stanek, L. W., Brown, J. S., Stanek, J., Gift, J. & Costa, D. L. Air pollution toxicology—a brief review of the role of the science in shaping the current understanding of air pollution health risks. Toxicol. Sci. 120, S8–27 (2011).
Klingbeil, E. C., Hew, K. M., Nygaard, U. C. & Nadeau, K. C. Polycyclic aromatic hydrocarbons, tobacco smoke, and epigenetic remodeling in asthma. Immunol. Res. 58, 369–73 (2014).
Rosa, M. J., Jung, K. H., Perzanowski, M. S., Kelvin, E. A., Darling, K. W. & Camann, D. E. et al. Prenatal exposure to polycyclic aromatic hydrocarbons, environmental tobacco smoke and asthma. Respir. Med. 105, 869–76 (2011).
Flory, J. H., Sleiman, P. M., Christie, J. D., Annaiah, K., Bradfield, J. & Kim, C. E. et al. 17q12-21 variants interact with smoke exposure as a risk factor for pediatric asthma but are equally associated with early-onset versus late-onset asthma in North Americans of European ancestry. J. Allergy Clin. Immunol. 124, 605–7 (2009).
Jolly, P. S., Rosenfeldt, H. M., Milstien, S. & Spiegel, S. The roles of sphingosine-1-phosphate in asthma. Mol. Immunol. 38, 1239–45 (2002).
Acknowledgements
This work was supported, in part, by grants from the National Health Research Institutes, Taiwan (EOPP10-014 and EOSP07-014 to S.-K.H.), Kaohsiung Medical University “The Talent Plan” (105KMUOR04 to S.-K.H.), the Ministry of Science and Technology, Taiwan (MOST 105-2320-B-039-004 and MOST 106-2320-B-039-037, to H.-C.W.), China Medical University Hospital, Taiwan (DMR-106-154 and DMR-107-117, to H.-C.W.), the Community Medicine Research Center, Chang Gung Memorial Hospital at Keelung (CMRPG3E1183 to L.-C.C.), the 1000 Young Talents Plan Program, China (to Y.Z.), the Initial Funding for New PI, Fudan Children’s Hospital and Fudan University (to Y.Z.), the National Natural Science Foundation of China (81671561, to Y.Z.), and the National Key Research and Development Program of China (2016YFC1305102, to Y.Z.). We thank the Center for Research Resources and Development of Kaohsiung Medical University for providing the Olympus FV1000 confocal microscope.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Wang, HC., Wong, TH., Wang, LT. et al. Aryl hydrocarbon receptor signaling promotes ORMDL3-dependent generation of sphingosine-1-phosphate by inhibiting sphingosine-1-phosphate lyase. Cell Mol Immunol 16, 783–790 (2019). https://doi.org/10.1038/s41423-018-0022-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41423-018-0022-2